Cargando…
Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling
BACKGROUND: Human cerebral malaria (HCM) is a severe form of malaria characterized by sequestration of infected erythrocytes (IRBCs) in brain microvessels, increased levels of circulating free heme and pro-inflammatory cytokines and chemokines, brain swelling, vascular dysfunction, coma, and increas...
Autores principales: | Liu, Mingli, Solomon, Wesley, Cespedes, Juan Carlos, Wilson, Nana O., Ford, Byron, Stiles, Jonathan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894207/ https://www.ncbi.nlm.nih.gov/pubmed/29636063 http://dx.doi.org/10.1186/s12974-018-1147-z |
Ejemplares similares
-
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
por: Solomon, Wesley, et al.
Publicado: (2014) -
Neuregulin-1/ErbB4 signaling modulates Plasmodium falciparum HRP2-induced damage to brain cortical organoids
por: Harbuzariu, Adriana, et al.
Publicado: (2022) -
On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity
por: Ledonne, Ada, et al.
Publicado: (2019) -
Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases
por: Kobayashi, Yutaro, et al.
Publicado: (2019) -
Neuregulin-1-mediated ErbB2–ErbB3 signalling protects human trophoblasts against apoptosis to preserve differentiation
por: Fock, Valerie, et al.
Publicado: (2015)